Abiopharma

Caribou Biosciences to Participate in Upcoming Investor Conferences

Novanta Announces Financial Results for the Third Quarter 2025

Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

Chiesi Global Rare Diseases and Protalix BioTherapeutics Seek Re-examination from the EMA for the Negative Opinion for Elfabrio (pegunigalsidase alfa) Alternative Dosing Regimen of Every Four Weeks in the EU

Olema Oncology to Participate in Upcoming Investor Conferences

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

HealthStream Announces Third Quarter 2025 Results

NANOBIOTIX to Participate in Investor Conferences the Week of November 10th

Myomo to Report Third Quarter 2025 Financial Results on November 10

Eastman Announces Third-Quarter 2025 Financial Results